Mai-tram Vo
Ulsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
DRG2 Deficient Mice Exhibit Impaired Motor Behaviors with Reduced Striatal Dopamine Release.
Journal: International journal of molecular sciences
Published: November 11, 2019
Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells.
Journal: Biochemical and biophysical research communications
Published: October 14, 2019
DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expression.
Journal: The FEBS journal
Published: January 25, 2019
Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells.
Journal: Molecular biology of the cell
Published: January 17, 2019
Developmentally regulated GTP-binding protein 2 depletion leads to mitochondrial dysfunction through downregulation of dynamin-related protein 1.
Journal: Biochemical and biophysical research communications
Published: March 16, 2017
Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
Journal: Molecules and cells
Published: September 23, 2013
Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.
Journal: The Journal of biological chemistry
Published: June 16, 2012
Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28.
Journal: Nucleic acids research
Published: January 03, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026